OMCL logo

OMNICELL INC

OMCLNASDAQ
πŸ† #1761 by market capEarnings Oct 29US Equity
$36.86β–Ό $0.45 (βˆ’1.21%)
Market closed Β· at close
1hβ€”
24hβ–Ό 1.2%
7dβ–Ό 0.9%
14dβ–Ό 10.8%
30dβ–Ό 21.0%
1yβ–² 16.9%
🏦Market Cap
$1.68B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+8.4%
Slowing
πŸ“ŠGross Margin
44.8%
Healthy
πŸ’΅FCF Margin
10.0%
Moderate
βš–οΈP/S Ratio
1.4x
Cheap
Otter Score
50
Weak

Trading Snapshot

Day Range
$36.42 – $37.44
52-Week Range
$29.06 – $55.00
Volume
$2.34B
Avg Volume
$2.87B
Shares Outstanding
45.5M
Next Earnings
Sep 28, 2026

Fundamentals Snapshot

Annual Revenue
$1.18B
Last Q Revenue
$312M
P/E Ratio
43.3
P/S Ratio
1.4x
EPS (TTM)
$0.85
Dividend Yield
β€”

Why Investors Own OMCL

  • βœ“High-growth profile β€” revenue up +52.7% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 54% gross margin and 30% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.18Bβ–² +58.0% YoY
Gross Margin (TTM)
53.8%β–² +3.5% YoY
Operating Income (TTM)
$361Mβ–² +58.0% YoY
Free Cash Flow (TTM)
$353Mβ–² +58.0% YoY

About OMNICELL INC

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Price Target

β“˜
Average Target
$37.60
β–² +2.0% Upside
High Target$45.65
Low Target$32.85
Based on 11 analysts

Latest News & Updates